Literature DB >> 2397591

Postnatal development of the wild-type and weaver cerebellum after embryonic administration of propylthiouracil (PTU).

R J Smeyne1, D Goldowitz.   

Abstract

In this study we used propylthiouracil (PTU), a thyroid hormone-inhibiting compound, to render +/+, wv/+, and wv/wv embryos hypothyroid in order to test if the appearance of external granule layer (EGL) cell death in the weaver cerebellum is affected by alteration of granule cell development. At birth, the number of EGL cells in the PTU-treated cerebellum was reduced, compared to control animals, by 50%. Also, the amount of cell death was reduced in the PTU-treated wv/wv cerebellum. As adults, no differences were seen between PTU-treated and untreated mutant or normal cerebella. If the hypothyroid treatment that results in a 50% decrease in EGL cell number is due to an extension of cell cycling time, then the expression of the weaver phenotype of cell death likely follows granule cell exit from the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397591     DOI: 10.1016/0165-3806(90)90151-n

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  4 in total

1.  Modular organization of the granular layer of the human cerebellar cortex during post-natal ontogenesis.

Authors:  T A Tsekhmistrenko
Journal:  Neurosci Behav Physiol       Date:  2001 Jan-Feb

2.  Rescue of cerebellar granule cells from death in weaver NR1 double mutants.

Authors:  P Jensen; D J Surmeier; D Goldowitz
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

3.  Abnormalities in premigratory granule cells in the weaver cerebellum defined by monoclonal antibody OZ42.

Authors:  R J Smeyne; L B Pickford; R V Rouse; J Napieralski; D Goldowitz
Journal:  Anat Embryol (Berl)       Date:  1991

4.  The weaver mutation of GIRK2 results in a loss of inwardly rectifying K+ current in cerebellar granule cells.

Authors:  D J Surmeier; P G Mermelstein; D Goldowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.